We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Tenet Healthcare (THC) Outperforming Other Medical Stocks This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Tenet Healthcare (THC - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
Tenet Healthcare is a member of the Medical sector. This group includes 978 individual stocks and currently holds a Zacks Sector Rank of #16. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. THC is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for THC's full-year earnings has moved 64.91% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Based on the latest available data, THC has gained about 39.19% so far this year. Meanwhile, stocks in the Medical group have lost about 0.22% on average. This shows that Tenet Healthcare is outperforming its peers so far this year.
Breaking things down more, THC is a member of the Medical - Hospital industry, which includes 7 individual companies and currently sits at #89 in the Zacks Industry Rank. On average, this group has gained an average of 12.17% so far this year, meaning that THC is performing better in terms of year-to-date returns.
Investors with an interest in Medical stocks should continue to track THC. The stock will be looking to continue its solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is Tenet Healthcare (THC) Outperforming Other Medical Stocks This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Tenet Healthcare (THC - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
Tenet Healthcare is a member of the Medical sector. This group includes 978 individual stocks and currently holds a Zacks Sector Rank of #16. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. THC is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for THC's full-year earnings has moved 64.91% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Based on the latest available data, THC has gained about 39.19% so far this year. Meanwhile, stocks in the Medical group have lost about 0.22% on average. This shows that Tenet Healthcare is outperforming its peers so far this year.
Breaking things down more, THC is a member of the Medical - Hospital industry, which includes 7 individual companies and currently sits at #89 in the Zacks Industry Rank. On average, this group has gained an average of 12.17% so far this year, meaning that THC is performing better in terms of year-to-date returns.
Investors with an interest in Medical stocks should continue to track THC. The stock will be looking to continue its solid performance.